See more : Radius Health, Inc. (RDUS) Income Statement Analysis – Financial Results
Complete financial analysis of ValiRx plc (VAL.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ValiRx plc, a leading company in the Biotechnology industry within the Healthcare sector.
- Tsumura & Co. (TSMRF) Income Statement Analysis – Financial Results
- Yamaha Motor Co., Ltd. (YAMHF) Income Statement Analysis – Financial Results
- Network-1 Technologies, Inc. (NTIP) Income Statement Analysis – Financial Results
- Silver Grail Resources Ltd. (SVGAF) Income Statement Analysis – Financial Results
- Organización Cultiba, S.A.B. de C.V. (CULTIBAB.MX) Income Statement Analysis – Financial Results
ValiRx plc (VAL.L)
About ValiRx plc
ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a small molecule that has completed Phase I/II trials for the treatment of prostate cancer and other hormone associated solid tumours comprising breast and ovarian cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer. Its drug candidates also comprise VAL301, a peptide ingredient that in pre-clinical development for the treatment of women with endometriosis; and BC201, a combination of the peptide ingredient of VAL201/VAL301 with complementary active components for the treatment for patients suffering severe symptoms of Covid-19. ValiRx plc was incorporated in 2000 and is based in Hatfield, the United Kingdom.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2005 | 2004 | 2003 | 2002 | 2001 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 9.60K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 82.60K | 87.56K | 124.87K | 216.27K | 455.00K | 177.00K | 8.00K | 31.00K | 42.00K | 0.00 | 0.00 | 0.00 | 17.00K | 991.00K |
Cost of Revenue | 255.64K | 224.27K | 228.79K | 229.50K | 182.81K | 142.99K | 187.69K | 102.84K | 77.88K | 61.03K | 51.62K | 72.96K | 27.00K | 56.00K | 3.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 380.00K |
Gross Profit | -246.04K | -224.27K | -228.79K | -229.50K | -182.81K | -142.99K | -187.69K | -102.84K | 4.73K | 26.53K | 73.25K | 143.31K | 428.00K | 121.00K | 5.00K | 31.00K | 42.00K | 0.00 | 0.00 | 0.00 | 17.00K | 611.00K |
Gross Profit Ratio | -2,562.95% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.72% | 30.30% | 58.66% | 66.26% | 94.07% | 68.36% | 62.50% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 100.00% | 61.65% |
Research & Development | 383.36K | 551.23K | 303.79K | 230.12K | 984.46K | 1.70M | 1.75M | 2.38M | 1.54M | 1.77M | 1.62M | 1.01M | 420.00K | 120.00K | 73.00K | 146.00K | 156.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 1.89M | 1.50M | 1.22M | 1.43M | 1.86M | 2.17M | 1.47M | 1.79M | 1.69M | 1.60M | 1.36M | 1.48M | 1.09M | 463.00K | 1.03M | 1.03M | 716.00K | 134.00K | 345.00K | 86.00K | 1.11M | 3.57M |
Selling & Marketing | -218.10K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 1.67M | 1.50M | 1.22M | 1.43M | 1.86M | 2.17M | 1.47M | 1.79M | 1.69M | 1.60M | 1.36M | 1.48M | 1.09M | 463.00K | 1.03M | 1.03M | 716.00K | 134.00K | 345.00K | 86.00K | 1.11M | 3.57M |
Other Expenses | 0.00 | 539.79K | 157.66K | -11.08K | -146.52K | 506.76K | -88.77K | 0.00 | -203.39K | -210.80K | 0.00 | 0.00 | -14.00K | 702.00K | -346.00K | -646.00K | -451.00K | 0.00 | 0.00 | 0.00 | 3.49M | 5.32M |
Operating Expenses | 2.05M | 2.59M | 1.68M | 1.65M | 2.70M | 4.37M | 3.13M | 4.17M | 3.03M | 3.16M | 2.98M | 2.49M | 1.51M | 583.00K | 1.03M | 1.07M | 883.00K | 134.00K | 345.00K | 86.00K | 1.11M | 3.57M |
Cost & Expenses | 2.31M | 2.59M | 1.68M | 1.65M | 2.70M | 4.37M | 3.13M | 4.17M | 3.11M | 3.23M | 3.04M | 2.57M | 1.54M | 639.00K | 1.03M | 1.07M | 883.00K | 134.00K | 345.00K | 86.00K | 1.11M | 3.95M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 489.00 | 17.00 | 1.07K | 8.02K | 5.55K | 19.00K | 21.00K | 1.00 | 0.00 | 5.00K | 13.00K | 0.00 | 0.00 | 0.00 | 2.00K | 90.00K |
Interest Expense | 4.42K | 5.46K | 2.77K | 14.88K | 21.18K | 14.57K | 449.87K | 338.19K | 1.79K | 1.53K | 180.00 | 21.00 | 1.00K | 8.00K | 3.00K | 3.00K | 1.37M | 0.00 | 0.00 | 64.00K | 0.00 | 0.00 |
Depreciation & Amortization | 254.20K | 224.27K | 228.79K | 229.50K | 182.81K | 142.99K | 187.69K | 102.84K | 102.74K | 91.21K | 61.16K | 55.34K | 34.00K | 31.00K | 26.00K | 19.00K | 11.00K | 0.00 | 0.00 | 0.00 | 34.00K | 881.00K |
EBITDA | -2.04M | -2.37M | -1.45M | -1.31M | -2.53M | -4.69M | -2.92M | -5.31M | -2.14M | -3.55M | -2.84M | -2.27M | -1.03M | -431.00K | -1.24M | -1.87M | -368.00K | -134.00K | -345.00K | -86.00K | -2.80M | -5.22M |
EBITDA Ratio | -21,295.17% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,541.76% | -3,470.72% | -2,277.91% | -1,051.72% | -226.37% | -243.50% | -12,437.50% | -3,877.42% | -1,945.24% | 0.00% | 0.00% | 0.00% | -16,488.24% | -526.74% |
Operating Income | -2.30M | -2.59M | -1.68M | -1.65M | -2.70M | -3.87M | -3.13M | -4.17M | -3.03M | -3.14M | -2.91M | -2.35M | -1.06M | -455.00K | -1.02M | -1.22M | 83.00K | -134.00K | -345.00K | -86.00K | -2.84M | -6.10M |
Operating Income Ratio | -23,943.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,667.43% | -3,584.06% | -2,331.33% | -1,086.09% | -233.63% | -257.06% | -12,762.50% | -3,938.71% | 197.62% | 0.00% | 0.00% | 0.00% | -16,688.24% | -615.64% |
Total Other Income/Expenses | -4.42K | -5.46K | -2.77K | 107.12K | -21.18K | -460.66K | -428.68K | -1.58M | 462.36K | -503.20K | 5.37K | 18.98K | 19.42K | 1.35M | -244.00K | -667.00K | -911.00K | 0.00 | 0.00 | -64.00K | 0.00 | 597.00K |
Income Before Tax | -2.30M | -2.60M | -1.68M | -1.54M | -2.72M | -4.83M | -3.55M | -5.75M | -2.57M | -3.64M | -2.91M | -2.33M | -1.07M | 179.00K | -1.27M | -1.89M | -1.29M | -134.00K | -345.00K | -150.00K | -2.84M | -5.50M |
Income Before Tax Ratio | -23,989.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,107.76% | -4,158.77% | -2,327.03% | -1,077.32% | -234.07% | 101.13% | -15,812.50% | -6,090.32% | -3,071.43% | 0.00% | 0.00% | 0.00% | -16,688.24% | -555.40% |
Income Tax Expense | -175.17K | -192.67K | -133.41K | -75.18K | -293.74K | -461.30K | -416.34K | -620.10K | -391.20K | -396.86K | -308.48K | -165.96K | -132.00K | -35.00K | -163.00K | 632.00K | 1.32M | 0.00 | 0.00 | 64.00K | 22.00K | -622.00K |
Net Income | -2.04M | -2.41M | -1.55M | -1.47M | -2.43M | -4.37M | -3.14M | -4.75M | -2.12M | -3.16M | -2.60M | -2.16M | -933.00K | 134.00K | -1.44M | -1.86M | -1.24M | -134.00K | -345.00K | -150.00K | -2.86M | -5.48M |
Net Income Ratio | -21,226.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -2,564.48% | -3,609.07% | -2,079.99% | -1,000.58% | -205.05% | 75.71% | -18,037.50% | -5,987.10% | -2,952.38% | 0.00% | 0.00% | 0.00% | -16,817.65% | -552.88% |
EPS | -0.02 | -0.03 | -0.02 | -0.04 | -0.34 | -1.19 | -2.60 | -10.28 | -8.33 | -2.11K | -23.42 | -26.25 | -15.42 | 15.63 | -177.45 | -645.12 | -646.51 | -985.29 | -65.07 | -9.48 | -180.63 | -346.16 |
EPS Diluted | -0.02 | -0.03 | -0.02 | -0.04 | -0.34 | -1.19 | -2.60 | -10.28 | -8.33 | -2.11K | -23.42 | -26.25 | -15.42 | 15.63 | -177.45 | -645.12 | -646.51 | -985.29 | -65.07 | -9.48 | -180.63 | -346.16 |
Weighted Avg Shares Out | 101.57M | 77.30M | 65.00M | 37.90M | 7.22M | 3.67M | 1.21M | 461.95K | 254.32K | 1.50K | 110.92K | 82.44K | 60.51K | 19.60K | 8.13K | 2.88K | 1.92K | 136.00 | 5.30K | 15.83K | 15.83K | 15.83K |
Weighted Avg Shares Out (Dil) | 101.57M | 77.30M | 65.00M | 37.90M | 7.22M | 3.67M | 1.21M | 461.95K | 254.32K | 1.50K | 110.92K | 82.44K | 60.51K | 19.60K | 8.13K | 2.88K | 1.92K | 136.00 | 5.30K | 15.83K | 15.83K | 15.83K |
Source: https://incomestatements.info
Category: Stock Reports